Company
Respira
Respira Therapeutics
Also known as Respira Therapeutics Inc
- Business model
- B2B
- Legal name
- Respira Therapeutics Inc
Claim, correct or request removal
Record updated 29 September 2026
About
Respira is a clinical-stage inhaled therapeutics company developing next-generation pulmonary targeted therapeutics to address significant unmet patient needs in cardio-pulmonary diseases.
Funding snapshot
- Total raised
- $9.1MSEC form D sum, as of 2026-09-29Source (opens in a new tab)
- Latest round
- Round, $9.1M2017-04-11
Funding rounds
- Round, 2017
- $9.1M2017-04-11, SEC form D sold, 3 investors
Loading relationship preview